Getting Started
Read all the information presented below. When ready select the "View Program" tab above.
Claiming CME/CE Credits
To receive credits, participants must review the program materials in their entirety and complete the online post examination and evaluation. CME credits require a post examination score of 70% or higher. CE credits require a post examination score of 80% or higher.
MRI technology has advanced with the availability of low - vertical field scanners. However, many patients present with passive implants and devices that are available in clinical practice, yet not approved for MR imaging in low field scanners.
In this CME/CE program three MR imaging experts will provide unique perspectives on managing patients with passive implants and devices. The panel will discuss important MRI safety information and details on how to safely image these patients, including a review of screening policies, implant and device manufacturers’ information and resources, and the implementation plan for a MRI safety program, designed to mitigate the potential risks to patients presenting with passive implants and devices.
CME Effective Date: August 1, 2022
CME Expiration Date: July 31, 2024
CE Effective Date: August 10, 2022
CE Expiration Date: August 31, 2025
Format: Self Instructional - Audio Visual with Slides
Educational Credits:
One (1) AMA/PRA Category 1 CME Credit™
One (1) ARRT Category A CE Credit.
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour
This program is made possible through an unrestricted educational grant from FUJIFILM Healthcare Americas
This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.
There is no cost to participate in this program.
Upon completion of this CME/CE activity the healthcare provider should be able to:
Lawrence N. Tanenbaum, M.D. FACR
Vice President and Medical Director Eastern Division
Director of MRI, Computed Tomography, and Advanced Imaging
RadNet Inc., New York, NY
Lawrence N Tanenbaum MD, FACR is currently Vice President & Chief Technology Officer at RadNet, Inc., a leading provider of freestanding, fixed-site diagnostic imaging services in the United States, where he also serves as Medical Director for the Eastern Region. Prior to this role, Dr. Tanenbaum served as Associate Professor of Radiology and Director of MRI/CT & Outpatient / Advanced Imaging Development at the Icahn School of Medicine at Mount Sinai in New York.
Dr. Tanenbaum has authored approximately 100 scholarly and peer reviewed articles, continues to chair educational and academic meetings and has delivered over 1500 invited lectures around the world.
Frank G. Shellock, Ph.D, FACR, FACC, FISMRM
Director of MRI Safety
USC Stevens Neuroimaging and Informatics Institute
Adjunct Clinical Professor of Radiology and Medicine,
Keck School of Medicine, University of Southern California,
Los Angeles, California
Frank G. Shellock, Ph.D. is a physiologist with more than 30 years of experience conducting clinical and laboratory investigations in the field of magnetic resonance imaging (MRI). He is an Adjunct Clinical Professor of Radiology and Medicine at the Keck School of Medicine, University of Southern California, and the Director of MRI Studies at the Biomimetic Microelectronic Systems, National Science Foundation (NSF) - Engineering Research Center, University of Southern California.
Dr. Shellock is the creator of the internationally popular website,www.mrisafety.com, the author of two best selling medical textbooks (Reference Manual for Magnetic Resonance Safety, Implants, and Devices and MRI Bioeffects, Safety, and Patient Management), and by being involved as a researcher in virtually ever aspect of MRI safety, Dr. Shellock is uniquely qualified to present this educational program.
William Faulkner, B.S.,R.T.(R)(MR)(CT), FSMRT, MRSO (MRSC™)
William Faulkner & Associates
Bill Faulkner is an independent consultant for over 20 years with William Faulkner & Associates, which provides MRI and CT education as well as MRI safety audits and clinical operations consulting.
He is an active member and Fellow of the SMRT and is a founding board member of the American Board of Magnetic Resonance Safety (ABMRS). Bill is the author of “Rad Techs Guide to MRI: Basic Physics, Instrumentation and Quality Control”. He is the co-author of “Review Questions for MRI” and a contributing author for “MRI for Technologists”, “Handbook for MRI”, and the first edition of “The Physics of Clinical MR Taught Through Images”.
IAME requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.
Planner
Erin Simon Schwartz, MD, FACR, discloses no financial relationships with any ineligible companies.
Presenters
Lawrence N. Tanenbaum, MD, FACR, discloses relationships with the following ineligible companies:
GE, Siemens, Philips, Fuji, Guerbet, Agamon, iMedis, Ezra, Voxel.ai, Aidoc, and icometrix.
Frank Shellock, Ph.D., FACR, FACC, FISMRM, discloses relationships with the following ineligible companies:
Fujifilm
William Faulkner, BS,RT(R)(MR)(CT), FSMRT, MRSO (MRSC™), discloses no relevant financial relationships with ineligible companies.
Mitigation
Relationships with any ineligible companies were mitigated by a content review by Dr. Jason Cox, who has no relevant financial relationships with ineligible companies.
No individual(s) at the Institute for Advanced Medical Education or Anderson Publishing who had control over the planning or content of this activity has relevant financial relationships with ineligible companies.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of IAME and Anderson Publishing. IAME is accredited by the ACCME to provide continuing medical education for physicians. IAME designates this internet activity for a maximum of one (1) AMA PRA Category 1 Credit™.
Radiologic Technologists:
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.
Radiology Administrators:
This course meets all CRA renewal credit criteria and has been approved for One (1) continuing education credit in the following CRA domains: Operations Management (OM).
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
CME Credits
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.
CE Credits
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.
Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.